| scholarly article | Q13442814 |
| P50 | author | Stefanie Dimmeler | Q110856 |
| Andreas Zeiher | Q501318 | ||
| Christopher Heeschen | Q18347525 | ||
| Ulrike Koehl | Q44365288 | ||
| Alexandra Aicher | Q86950497 | ||
| Winfried Brenner | Q89882342 | ||
| Thomas Eckey | Q117267698 | ||
| Schirin Massoudi | Q117267699 | ||
| Maaz Zuhayra | Q117267700 | ||
| Eberhard Henze | Q117267701 | ||
| P2093 | author name string | Willm U Kampen | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 512-518 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model | |
| P478 | volume | 45 |
| Q37993772 | Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma |
| Q42861069 | An imperfect syllogism: granulocyte colony-stimulating factor mobilization and cardiac regeneration |
| Q33680007 | Assessment and optimization of cell engraftment after transplantation into the heart |
| Q53620684 | Assessment of the metabolic activity of bone grafts with (18)F-fluoride PET. |
| Q37178066 | Bioengineering to enhance progenitor cell therapeutics |
| Q52943377 | Bone Marrow Cell Trafficking Analyzed by 89Zr-oxine Positron Emission Tomography in a Murine Transplantation Model |
| Q37967719 | CD34-positive stem cells: in the treatment of heart and vascular disease in human beings |
| Q36576314 | CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism |
| Q33934547 | CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction |
| Q36579504 | Cardiac repair--fact or fancy? |
| Q61942655 | Cathelicidin Related Antimicrobial Peptide (CRAMP) Enhances Bone Marrow Cell Retention and Attenuates Cardiac Dysfunction in a Mouse Model of Myocardial Infarction |
| Q38014708 | Cell delivery routes for stem cell therapy to the heart: current and future approaches. |
| Q40660723 | Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials |
| Q37187645 | Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction |
| Q35589728 | Cell tracking in cardiac repair: what to image and how to image. |
| Q28084529 | Cell tracking technologies for acute ischemic brain injury |
| Q36277263 | Cell-based therapies and imaging in cardiology |
| Q37731741 | Challenges in the translation of cardiovascular cell therapy |
| Q26851906 | Clinical imaging in regenerative medicine |
| Q40171747 | Comparison of imaging techniques for tracking cardiac stem cell therapy |
| Q35200156 | Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies |
| Q34768493 | Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma. |
| Q30477220 | Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction |
| Q53012778 | Effects of acute exercise on markers of inflammation in pediatric chronic kidney disease: a pilot study |
| Q35944159 | Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective |
| Q34055868 | Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix |
| Q31058133 | Enhancement of Cell-Based Therapeutic Angiogenesis Using a Novel Type of Injectable Scaffolds of Hydroxyapatite-Polymer Nanocomposite Microspheres |
| Q53544638 | Feasibility of in vivo dual-energy myocardial SPECT for monitoring the distribution of transplanted cells in relation to the infarction site |
| Q38889816 | Fluorescence-guided development of a tricistronic vector encoding bimodal optical and nuclear genetic reporters for in vivo cellular imaging |
| Q28078109 | Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach |
| Q35181871 | High-dose (111)in induces g1 cell cycle arrest and cell death in rat bone marrow mesenchymal stem cells. |
| Q33760563 | Imaging approaches for the study of cell-based cardiac therapies |
| Q38168207 | Imaging cardiac stem cell transplantation using radionuclide labeling techniques: clinical applications and future directions. |
| Q34340761 | Imaging of Cells and Nanoparticles: Implications for Drug Delivery to the Brain |
| Q36656791 | Imaging stem cells implanted in infarcted myocardium |
| Q39631337 | Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo |
| Q58596804 | Impaired adhesion of induced pluripotent stem cell-derived cardiac progenitor cells (iPSC-CPCs) to isolated extracellular matrix from failing hearts |
| Q26765900 | In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine |
| Q37440349 | In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods |
| Q90216409 | In vivo tracking of intravenously injected mesenchymal stem cells in an Alzheimer's animal model |
| Q61612309 | Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells |
| Q48932406 | Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: effect on cell proliferation and differentiation |
| Q35963080 | MRI/SPECT/Fluorescent Tri-Modal Probe for Evaluating the Homing and Therapeutic Efficacy of Transplanted Mesenchymal Stem Cells in a Rat Ischemic Stroke Model |
| Q36861531 | Magnetic Resonance Imaging and Fluorescence Labeling of Clinical-Grade Mesenchymal Stem Cells Without Impacting Their Phenotype: Study in a Rat Model of Stroke |
| Q90683736 | Mending a broken heart: current strategies and limitations of cell-based therapy |
| Q34807143 | Methods to assess stem cell lineage, fate and function |
| Q38804978 | New strategies for improving stem cell therapy in ischemic heart disease |
| Q38129057 | Non-invasive In-Vivo Imaging of Stem Cells after Transplantation in Cardiovascular Tissue |
| Q37767614 | Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. |
| Q37938642 | Noninvasive cell-tracking methods |
| Q33576955 | Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery |
| Q37907966 | Noninvasive stem cell tracking |
| Q35462110 | Novel (89)Zr cell labeling approach for PET-based cell trafficking studies |
| Q36666478 | Nuclear imaging in cardiac cell therapy |
| Q90323421 | Optical fluorescence imaging with shortwave infrared light emitter nanomaterials for in vivo cell tracking in regenerative medicine |
| Q90450109 | Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models |
| Q34277673 | Period2 deficiency blunts hypoxia-induced mobilization and function of endothelial progenitor cells |
| Q36848798 | Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34+Bone Marrow Mononuclear Cells |
| Q37606452 | Pulp cell tracking by radionuclide imaging for dental tissue engineering. |
| Q48692331 | Radiolabeling strategies for radionuclide imaging of stem cells |
| Q38225145 | Radiopharmaceutical stem cell tracking for neurological diseases |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q42205516 | Role of stromal-derived factor-1 |
| Q30420004 | Seeing stem cells at work in vivo. |
| Q43239856 | Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells |
| Q37496418 | Skeletal muscle satellite cell migration to injured tissue measured with 111In-oxine and high-resolution SPECT imaging |
| Q57463397 | Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury |
| Q39124190 | Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise |
| Q39762671 | Stem Cell Tracking in Human Trials: A Meta-Regression |
| Q34988926 | Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy |
| Q36836349 | Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology |
| Q53413645 | Stem cell: "KANT" you see it? |
| Q45354313 | Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair |
| Q35053611 | The role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervation, and future applications |
| Q34502807 | Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging |
| Q35691795 | Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques |
| Q79449730 | [Cell tracking. Principles and applications] |
Search more.